Efficacy and safety of vitamin K2 for postmenopausal women with osteoporosis at a long-term follow-up: meta-analysis and systematic review.
- 2022-06-16
- Meta-Analysis · n = 6,853
- Journal of bone and mineral metabolism 40(5)
- Ming Zhou
- Shiliang Han
- Wenpeng Zhang
- Dan Wu
- PubMed: 35711002
- DOI: 10.1007/s00774-022-01342-6
- High evidence
- Clinical
Adverse reaction analysis showed that there seemed to be higher adverse reaction rates in the vitamin K2 group (RR = 1.33, 95% CI [1.11-1.59]), but no serious adverse events related to vitamin K2 supplementation.
- Effect
- Harmful
- Effect size
- Moderate
- Significant
- Yes